EUVIMEDEUVIMED entdecken
Crossref

Sanguinarine suppresses oral squamous cell carcinoma progression by targeting the PKM2/TFEB aix to inhibit autophagic flux

Yong-Chun Peng, Zhi-Jing He, Lun-Cai Yin, Hui-Feng Pi, Yi Jiang, Ke-Yan Li, Li Tian, Jia Xie, Jian-Bo Zhang, Chen-Yao Li, Guan-Ying Feng, Kai Wang und 4 weitere

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2024.156337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Yong-Chun Peng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China. Hauptthemen laut MEDLINE: Autophagy, Mouth Neoplasms, Benzophenanthridines, Isoquinolines. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation, Science and Technology Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Oral squamous cell carcinoma (OSCC) is one of the most common malignancies. However, there is no effective treatment for OSCC. PURPOSE: This study aimed to identify a natural compound with significant efficacy against OSCC and elucidate its primary mechanism of action. METHODS: An FDA-approved drug library and an MCE autophagy-related molecular compound library were screened through high-throughput screening to identify an effective natural compound against OSCC. The IC50 value of sanguinarine (Sang) in OSCC cells was determined using a CCK8 assay. Immunoblotting and immunofluorescence staining were used to assess the effect of Sang on autophagic flux in OSCC cells. Changes in the acidic lysosomal environment were evaluated using RFP-GFP-LC3B and LysoSensor Green DND-189. Furthermore, limited proteolysis-coupled mass spectrometry (LiP-MS) and virtual screening techniques were utilized to identify direct binding targets of Sang, which were subsequently validated by surface plasmon resonance (SPR) and microscale thermophoresis (MST). Molecular docking combined with molecular dynamics analysis identified the binding site between the target protein and Sang. In vitro and in vivo investigations with mutant plasmids confirmed this finding. RESULTS: Screening led to the identification of the naturally occurring autophagy modulator Sang as a potent inhibitor of OSCC progression. Moreover, Sang impaired lysosomal function through reducing lysosomal-associated membrane proteins, inhibiting lysosomal proteolysis, and altering the lysosomal pH. These effects contributed to defects in autophagic clearance and subsequently suppressed OSCC progression. Notably, Sang bound the phenylalanine 26 (F26) residue in pyruvate kinase M2 (PKM2) and inhibited PKM2 enzymatic activity, subsequently suppressing transcription factor EB (TFEB) expression to inhibit lysosomal function and blocking autophagic flux in OSCC cells. CONCLUSION: Our results demonstrate for the first time that Sang can suppress the PKM2/TFEB axis, and influence lysosomal function, thereby blocking autophagy and inhibiting the progression of OSCC, making it a promising therapeutic option for the treatment of OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyMouth NeoplasmsBenzophenanthridinesIsoquinolinesCarrier ProteinsCarcinoma, Squamous CellBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsMembrane ProteinsThyroid HormonesHumansCell Line, TumorThyroid Hormone-Binding ProteinsMolecular Docking SimulationAnimalsMiceMice, NudeDisease Progression

Stichwörter der Autor:innen

AutophagyOral squamous cell carcinoma (OSCC)Sanguinarine (Sang)Transcription factor EB (TFEB)pyruvate kinase M2 (PKM2)

Substanzen

BenzophenanthridinessanguinarineIsoquinolinesThyroid Hormone-Binding ProteinsCarrier ProteinsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTFEB protein, humanMembrane ProteinsThyroid Hormones

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
  • Department of Oncology, Affiliated Dazu Hospital of Chongqing Medical University, Chongqing 402360, China.
  • Department of Occupational Health (Key Laboratory of Electromagnetic Radiation Protection, Ministry of Education), Army Medical University (Third Military Medical University), Chongqing 400038, China. State Key Laborato…
  • Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
  • Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Sto…
  • Department of Neurosurgery, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha, Hunan 410005, China.

Förderung

  • National Natural Science Foundation of China
  • Hunan Provincial Natural Science Foundation
  • Science and Technology Program of Hunan Province
  • Natural Science Foundation of Hainan Province

Zitieren

APA

Peng, Y. C., He, Z. J., Yin, L. C., Pi, H. F., Jiang, Y., Li, K. Y., Tian, L., Xie, J., Zhang, J. B., Li, C. Y., Feng, G. Y., Wang, K., Zhou, D. Z., Xie, X. W., Zhang, Z. Y., & Fan, T. F. (2025). Sanguinarine suppresses oral squamous cell carcinoma progression by targeting the PKM2/TFEB aix to inhibit autophagic flux. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.156337

Vancouver

Peng YC, He ZJ, Yin LC, Pi HF, Jiang Y, Li KY, et al. Sanguinarine suppresses oral squamous cell carcinoma progression by targeting the PKM2/TFEB aix to inhibit autophagic flux. Phytomedicine. 2025. doi:10.1016/j.phymed.2024.156337

BibTeX
@article{Peng2025,
  author = {Peng, Yong-Chun and He, Zhi-Jing and Yin, Lun-Cai and Pi, Hui-Feng and Jiang, Yi and Li, Ke-Yan and Tian, Li and Xie, Jia and Zhang, Jian-Bo and Li, Chen-Yao and Feng, Guan-Ying and Wang, Kai and Zhou, Ding-Zhou and Xie, Xiao-Wei and Zhang, Zhi-Yuan and Fan, Teng-Fei},
  title = {Sanguinarine suppresses oral squamous cell carcinoma progression by targeting the PKM2/TFEB aix to inhibit autophagic flux},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2024.156337}
}
Kostenlos starten →